ATE319833T1 - Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus - Google Patents
Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virusInfo
- Publication number
- ATE319833T1 ATE319833T1 AT00983967T AT00983967T ATE319833T1 AT E319833 T1 ATE319833 T1 AT E319833T1 AT 00983967 T AT00983967 T AT 00983967T AT 00983967 T AT00983967 T AT 00983967T AT E319833 T1 ATE319833 T1 AT E319833T1
- Authority
- AT
- Austria
- Prior art keywords
- type
- hsv
- nucleic acid
- protein
- mammal
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000700584 Simplexvirus Species 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 108020004707 nucleic acids Proteins 0.000 abstract 3
- 102000039446 nucleic acids Human genes 0.000 abstract 3
- 150000007523 nucleic acids Chemical class 0.000 abstract 3
- 108010041986 DNA Vaccines Proteins 0.000 abstract 2
- 229940021995 DNA vaccine Drugs 0.000 abstract 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 abstract 2
- 102000013462 Interleukin-12 Human genes 0.000 abstract 2
- 108010065805 Interleukin-12 Proteins 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
- 239000000833 heterodimer Substances 0.000 abstract 2
- 230000003053 immunization Effects 0.000 abstract 2
- 238000002649 immunization Methods 0.000 abstract 2
- 230000001681 protective effect Effects 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 229940117681 interleukin-12 Drugs 0.000 abstract 1
- 239000003589 local anesthetic agent Substances 0.000 abstract 1
- 229940023143 protein vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A61K2039/55538—IL-12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17231399P | 1999-12-17 | 1999-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE319833T1 true ATE319833T1 (de) | 2006-03-15 |
Family
ID=22627181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00983967T ATE319833T1 (de) | 1999-12-17 | 2000-12-07 | Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1238086B1 (de) |
| JP (1) | JP2003517042A (de) |
| KR (1) | KR100773390B1 (de) |
| CN (1) | CN1222619C (de) |
| AT (1) | ATE319833T1 (de) |
| AU (1) | AU783730B2 (de) |
| BR (1) | BR0016419A (de) |
| CA (1) | CA2406678A1 (de) |
| CY (1) | CY1105604T1 (de) |
| DE (1) | DE60026588T2 (de) |
| DK (1) | DK1238086T3 (de) |
| ES (1) | ES2258987T3 (de) |
| IL (1) | IL149810A0 (de) |
| MX (1) | MXPA02005867A (de) |
| PT (1) | PT1238086E (de) |
| WO (1) | WO2001044477A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004043376A2 (en) * | 2002-11-07 | 2004-05-27 | Synergy America, Inc. | Compositions and methods for treating or preventing pneumococcal infection |
| KR101746872B1 (ko) | 2009-05-22 | 2017-06-14 | 제노시아 바이오사이언스, 인크. | 단순 포진 바이러스 유형 2에 대한 백신: 면역 반응을 유도하는 조성물 및 방법 |
| KR101008582B1 (ko) * | 2010-09-20 | 2011-01-17 | (주)칠칠공사 | 달비계용 2중 안전 샤클조립체 |
| US9782474B2 (en) | 2010-11-24 | 2017-10-10 | Genocea Biosciences, Inc. | Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| US9624273B2 (en) | 2011-11-23 | 2017-04-18 | Genocea Biosciences, Inc. | Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| US9566325B2 (en) | 2013-01-07 | 2017-02-14 | Biomedical Research Models, Inc. | Therapeutic vaccines for treating herpes simplex virus type-2 infections |
| US10918712B2 (en) | 2014-03-03 | 2021-02-16 | Albert Einstein College Of Medicine | Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors |
| AU2015225499B2 (en) | 2014-03-03 | 2020-05-14 | Albert Einstein College Of Medicine, Inc. | Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors |
| CN104721839A (zh) * | 2015-03-17 | 2015-06-24 | 浙江省医学科学院 | 一种预防单纯疱疹病毒ii型的疫苗 |
| CN104830781A (zh) * | 2015-05-05 | 2015-08-12 | 杨光华 | 基于hsv-2抗原的dc细胞、靶向性免疫细胞群及其制备方法和用途 |
| WO2018064232A1 (en) | 2016-09-28 | 2018-04-05 | Genocea Biosciences, Inc. | Methods and compositions for treating herpes |
| AU2018323502B2 (en) * | 2017-08-30 | 2023-01-12 | Km Biologics Co., Ltd. | Modified HSV gD protein and vaccine containing same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002502884A (ja) * | 1998-02-12 | 2002-01-29 | アメリカン・サイアナミド・カンパニー | インターロイキン−１２および単純ヘルペスウイルス抗原を含んでなるワクチン |
-
2000
- 2000-12-07 KR KR1020027007752A patent/KR100773390B1/ko not_active Expired - Fee Related
- 2000-12-07 DE DE2000626588 patent/DE60026588T2/de not_active Expired - Fee Related
- 2000-12-07 CA CA 2406678 patent/CA2406678A1/en not_active Abandoned
- 2000-12-07 ES ES00983967T patent/ES2258987T3/es not_active Expired - Lifetime
- 2000-12-07 AU AU20651/01A patent/AU783730B2/en not_active Ceased
- 2000-12-07 WO PCT/US2000/033105 patent/WO2001044477A1/en not_active Ceased
- 2000-12-07 CN CNB008189188A patent/CN1222619C/zh not_active Expired - Fee Related
- 2000-12-07 MX MXPA02005867A patent/MXPA02005867A/es active IP Right Grant
- 2000-12-07 JP JP2001545554A patent/JP2003517042A/ja not_active Ceased
- 2000-12-07 BR BR0016419A patent/BR0016419A/pt not_active Application Discontinuation
- 2000-12-07 AT AT00983967T patent/ATE319833T1/de not_active IP Right Cessation
- 2000-12-07 EP EP00983967A patent/EP1238086B1/de not_active Expired - Lifetime
- 2000-12-07 DK DK00983967T patent/DK1238086T3/da active
- 2000-12-07 IL IL14981000A patent/IL149810A0/xx unknown
- 2000-12-07 PT PT00983967T patent/PT1238086E/pt unknown
-
2006
- 2006-04-17 CY CY20061100527T patent/CY1105604T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02005867A (es) | 2002-10-23 |
| CA2406678A1 (en) | 2001-06-21 |
| CN1434864A (zh) | 2003-08-06 |
| JP2003517042A (ja) | 2003-05-20 |
| EP1238086B1 (de) | 2006-03-08 |
| DE60026588T2 (de) | 2007-01-18 |
| EP1238086A1 (de) | 2002-09-11 |
| BR0016419A (pt) | 2002-08-20 |
| PT1238086E (pt) | 2006-07-31 |
| KR20020073348A (ko) | 2002-09-23 |
| ES2258987T3 (es) | 2006-09-16 |
| KR100773390B1 (ko) | 2007-11-09 |
| CY1105604T1 (el) | 2010-07-28 |
| DE60026588D1 (de) | 2006-05-04 |
| WO2001044477A1 (en) | 2001-06-21 |
| IL149810A0 (en) | 2002-11-10 |
| AU2065101A (en) | 2001-06-25 |
| AU783730B2 (en) | 2005-12-01 |
| CN1222619C (zh) | 2005-10-12 |
| DK1238086T3 (da) | 2006-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR0176265B1 (en) | Causative agent of the mystery swine disease, and vaccine compositions | |
| FI953608A7 (fi) | Rokoteyhdisteet ja menetelmä immuunireaktion aikaansaamiseksi limakalv ossa järjestelmällisellä rokottamisella | |
| CA2660355A1 (en) | Polynucleotide vaccine formulation against pathologies of the horse | |
| NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
| BRPI0408779A (pt) | uso de composições, composição imunogênica e kit | |
| EP1847549A3 (de) | Polyproteinkonstrukte des Papillomavirus | |
| NZ319377A (en) | polypeptides comprising a portion of a soluble M tuberculosis antigen | |
| EP2172551A3 (de) | Verbindungen zur Immuntherapie und Diagnose von Tuberkulose und Verfahren zu deren Verwendung | |
| IS4518A (is) | Nýtt lyfjaform fyrir bóluefni | |
| FR2814958B1 (fr) | Composition vaccinale | |
| ATE319833T1 (de) | Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus | |
| WO2002024739A3 (en) | Spas-1 cancer antigen | |
| BR0014138A (pt) | Uso de um vetor adenoviral deficiente em replicação, e, métodos para reforçar, e para induzir resposta imune de célula cd8+ t a um antìgeno em um indivìduo | |
| BR0206112A (pt) | Vacinas de ácido nucléico usando ácidos nucléicos de codificação de antìgeno de tumor com ácido nucleìco de codificação de auxiliar de citocina | |
| WO1999053960A3 (en) | Enhancing immune responses to genetic immunization by using a chemokine | |
| ATE381351T1 (de) | Anwendung des herpes simplex virus glykoproteins- d zur unterdrückung von immunantworten | |
| DE69922804D1 (de) | Verwendung von polymeren der hyaluronsäure zur mukosalen freigabe von impfstoffen und adjuvantien | |
| DK0524421T3 (da) | Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse | |
| ATE374622T1 (de) | Genetische impstoffe mit adjuvans | |
| BR0013574A (pt) | Antìgeno vacina de moraxella | |
| BR9905780A (pt) | Antìgenos vacinais de leptospira para prevenção da laptospirose | |
| ES2105984A1 (es) | Adenovirus recombinantes que expresan antigenos del virus de la gastroenteritis porcina transmisible (vgpt) y su empleo en la formacion de vacunas. | |
| WO1998058954A3 (en) | Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens | |
| NZ330913A (en) | Antigens for preventing and reducing parasite infection and disease | |
| BR0016740A (pt) | Antìgenos de esporozoìto de cryptosporidium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1238086 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |